What telehealth prescribing rules mean for patients crossing state lines
US telehealth prescribing is governed by state medical licensing: a clinician generally needs authority in the state where the patient is physically located during a consultation. This means moving or spending time in another state can disrupt care, despite telehealth being presented as widely accessible.
Patients who move may be reassigned to a clinician licensed in their new state, lose access to the provider, or face a delay that interrupts treatment. The article says GLP-1 treatment interruptions can require patients to revisit dose titration. For travel, the consultation and prescribing location matter; people who split their time between states are advised to check coverage, relocation procedures, possible supply gaps and whether consultations are available while away.
- Telehealth prescribing depends on the patient’s location.
- Moving can mean reassignment, lost access or a treatment gap.
- Check state coverage and continuity plans before starting.
New here? Start with this
Telehealth was promoted as expanding access to healthcare regardless of location, yet it remains constrained by state borders. In the United States, a doctor or clinician must generally be licensed to practise medicine in the state where a patient physically is during a consultation. This means that online care, despite its apparent flexibility, is still governed by traditional state-by-state medical licensing rules.
When patients move to a different state, this rule can disrupt their medical care. They may need to switch to a clinician licensed in their new state, lose access to a provider they have been seeing, or face delays whilst arrangements are made. Those who travel frequently or split their time between multiple states face similar complications.
For patients on ongoing treatments such as weight-loss medications, interruptions can be particularly problematic. Some medications require careful dose adjustments that can need to be restarted if treatment is paused. People considering a move or extended stay elsewhere are advised to check whether their current provider can continue their care, what the transition process involves, and whether there may be gaps in their medication supply.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
States maintain medical licensing to protect patients through locally accountable oversight and consistent regulation of practitioner standards. The current framework ensures states can enforce standards appropriate to their healthcare needs and prevents practitioners from operating under the weakest available regulatory regime. Whilst telehealth creates cross-border complications, eliminating state licensing requirements would sacrifice these protections without proven alternatives for ensuring patient safety.
The case against
Telehealth's central promise—providing care regardless of geography—is fundamentally undermined when state licensing forces patients to change providers upon relocation or creates treatment gaps during travel. Patients on time-sensitive medications like GLP-1 therapy face genuine medical harm from arbitrary interruptions whilst navigating state-specific rules. Interstate medical compacts demonstrate that patient safety can be maintained whilst enabling care continuity, suggesting the blanket restriction on cross-border prescribing prioritises regulatory convenience over actual patient outcomes.